440 related articles for article (PubMed ID: 16928680)
21. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
22. Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis.
Brunham LR; Singaraja RR; Duong M; Timmins JM; Fievet C; Bissada N; Kang MH; Samra A; Fruchart JC; McManus B; Staels B; Parks JS; Hayden MR
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):548-54. PubMed ID: 19201688
[TBL] [Abstract][Full Text] [Related]
23. Hepatic NPC1L1 promotes hyperlipidemia in LDL receptor deficient mice.
Wang Y; Tang W; Yang P; Shin H; Li Q
Biochem Biophys Res Commun; 2018 May; 499(3):626-633. PubMed ID: 29601818
[TBL] [Abstract][Full Text] [Related]
24. Aortic cholesterol accumulation correlates with systemic inflammation but not hepatic and gonadal adipose tissue inflammation in low-density lipoprotein receptor null mice.
Wang S; Miller B; Matthan NR; Goktas Z; Wu D; Reed DB; Yin X; Grammas P; Moustaid-Moussa N; Shen CL; Lichtenstein AH
Nutr Res; 2013 Dec; 33(12):1072-82. PubMed ID: 24267047
[TBL] [Abstract][Full Text] [Related]
25. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background increases hepatic ABCA1 mRNA expression and HDL-cholesterol.
Post SM; Groenendijk M; van der Hoogt CC; Fievet C; Luc G; Hoekstra M; Princen HM; Staels B; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2724-30. PubMed ID: 17008588
[TBL] [Abstract][Full Text] [Related]
26. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis.
Hsieh J; Koseki M; Molusky MM; Yakushiji E; Ichi I; Westerterp M; Iqbal J; Chan RB; Abramowicz S; Tascau L; Takiguchi S; Yamashita S; Welch CL; Di Paolo G; Hussain MM; Lefkowitch JH; Rader DJ; Tall AR
Nature; 2016 Jul; 535(7611):303-7. PubMed ID: 27383786
[TBL] [Abstract][Full Text] [Related]
27. High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-/- mice.
Wilund KR; Yu L; Xu F; Hobbs HH; Cohen JC
J Lipid Res; 2004 Aug; 45(8):1429-36. PubMed ID: 15175362
[TBL] [Abstract][Full Text] [Related]
28. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet.
Zhao Y; Pennings M; Hildebrand RB; Ye D; Calpe-Berdiel L; Out R; Kjerrulf M; Hurt-Camejo E; Groen AK; Hoekstra M; Jessup W; Chimini G; Van Berkel TJ; Van Eck M
Circ Res; 2010 Dec; 107(12):e20-31. PubMed ID: 21071707
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis.
Meiler S; Baumer Y; Toulmin E; Seng K; Boisvert WA
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):323-31. PubMed ID: 25524771
[TBL] [Abstract][Full Text] [Related]
30. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL.
Groen AK; Bloks VW; Bandsma RH; Ottenhoff R; Chimini G; Kuipers F
J Clin Invest; 2001 Sep; 108(6):843-50. PubMed ID: 11560953
[TBL] [Abstract][Full Text] [Related]
31. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.
Lv Y; Yang J; Gao A; Sun S; Zheng X; Chen X; Wan W; Tang C; Xie W; Li S; Guo D; Peng T; Zhao G; Zhong L
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):471-483. PubMed ID: 30950489
[TBL] [Abstract][Full Text] [Related]
32. Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.
Calpe-Berdiel L; Zhao Y; de Graauw M; Ye D; van Santbrink PJ; Mommaas AM; Foks A; Bot M; Meurs I; Kuiper J; Mack JT; Van Eck M; Tew KD; van Berkel TJ
Atherosclerosis; 2012 Aug; 223(2):332-41. PubMed ID: 22748276
[TBL] [Abstract][Full Text] [Related]
33. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
34. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis.
Meurs I; Lammers B; Zhao Y; Out R; Hildebrand RB; Hoekstra M; Van Berkel TJ; Van Eck M
Atherosclerosis; 2012 Mar; 221(1):41-7. PubMed ID: 22196936
[TBL] [Abstract][Full Text] [Related]
35. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
[TBL] [Abstract][Full Text] [Related]
36. ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis.
Ye D; Lammers B; Zhao Y; Meurs I; Van Berkel TJ; Van Eck M
Curr Drug Targets; 2011 May; 12(5):647-60. PubMed ID: 21039336
[TBL] [Abstract][Full Text] [Related]
37. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
[TBL] [Abstract][Full Text] [Related]
38. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
39. Hepatic ABCG5/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT.
Dikkers A; de Boer JF; Groen AK; Tietge UJ
Atherosclerosis; 2015 Dec; 243(2):402-6. PubMed ID: 26520893
[TBL] [Abstract][Full Text] [Related]
40. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
